Epigenetics: a novel therapeutic approach for the treatment of Alzheimer's disease.

Epigenetics: a novel therapeutic approach for the treatment of Alzheimer's disease.
复制标题

DOI:
10.1016/j.pharmthera.2013.03.010
复制
发表时间:
2013-07
影响因子:
13.5
通讯作者:
Zawia, Nasser H.
Zawia, Nasser H.
中科院分区:
医学1区
文献类型:
--
作者:
Adwan, Lina;Zawia, Nasser H.

文献摘要

参考文献

被引文献

相似文献

Alzheimer’s disease (AD) is the most common type of dementia in the elderly. It is characterized by the deposition of two forms of aggregates within the brain, the amyloid β plaques and tau neurofibrillary tangles. Currently, no disease-modifying agent is approved for the treatment of AD. Approved pharmacotherapies target the peripheral symptoms but they do not prevent or slow down the progression of the disease. Although several disease-modifying immunotherapeutic agents are in clinical development, many have failed due to lack of efficacy or serious adverse events. Epigenetic changes including DNA methylation and histone modifications are involved in learning and memory and have been recently highlighted for holding promise as potential targets for AD therapeutics. Dynamic and latent epigenetic alterations are incorporated in AD pathological pathways and present valuable reversible targets for AD and other neurological disorders. The approval of epigenetic drugs for cancer treatment has opened the door for the development of epigenetic drugs for other disorders including neurodegenerative diseases. In particular, methyl donors and histone deacetylase inhibitors are being investigated for possible therapeutic effects to rescue memory and cognitive decline found in such disorders. This review explores the area of epigenetics for potential AD interventions and presents the most recent findings in this field.
DOI: 10.1073/pnas.1012851108
发表时间: 2010-12-28
影响因子: 11.1
作者:
Caccamo, Antonella;Maldonado, Monica A.;Oddo, Salvatore
通讯作者: Oddo, Salvatore
DOI: 10.1016/j.jalz.2012.02.001
发表时间: 2012-03-01
影响因子: 14
作者:
通讯作者: --
DOI: 10.1074/jbc.m409024200
发表时间: 2004-12-03
影响因子: 4.8
作者:
Balasubramanyam, K;Varier, RA;Kundu, TK
通讯作者: Kundu, TK
DOI: 10.1016/s1474-4422(11)70072-2
发表时间: 2011-09
期刊: LANCET NEUROLOGY
影响因子: 48
作者:
Barnes, Deborah E.;Yaffe, Kristine
通讯作者: Yaffe, Kristine